Thanks for that. At least I know now I'm not insane. I have my 3 month post-radiation PSA test in two weeks and am seriously considering stopping ADT after that so I can hopefully be "me" again by the end of the year.

Thanks for sharing that! Here's the money quote:

❝
The role for hormonal treatment initially was restricted to men with metastatic and inoperable, locally advanced disease. Now it has been extended to neoadjuvant or adjuvant therapy for surgery and radiotherapy, for biochemical relapse after surgery or radiation, and even as primary therapy for non-metastatic disease.
❞

So the article seems to be focusing on whether proactive ADT always makes sense for early-stage (non-metastatic) prostate cancer; it's not questioning it for advanced stages.

There's a similar debate over proactive chemotherapy for advanced cancer that's still responding to ADT (castrate-sensitive).

In both cases, the question is whether it's better to hit it hard right at the start, or to avoid interventions that affect quality of life until we're sure they're needed. I suspect the answer to both is "well, it depends…" 😕